HYUNAH KIM: Open Payments
NPI 1679876742 · WHITE PLAINS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,102 in 40 payments from 13 companies in 2025. Trend: 2023 $1,183 · 2024 $575 · 2025 $1,102
Food & beverage: $1,102
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $299 |
| GENZYME CORPORATION | 1 | $116 |
| GlaxoSmithKline, LLC. | 4 | $101 |
| Corcept Therapeutics | 4 | $94 |
| Exact Sciences Corporation | 3 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $81 |
| SCPHARMACEUTICALS INC. | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Lilly USA, LLC | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
Products named: QULIPTA, UBRELVY, JARDIANCE, DUPIXENT, Korlym, Cologuard Collection Kit, FUROSCIX, FARXIGA.
Industry payments across NY — which companies pay providers there.
